What is Guardant Health's share buybacks?

Guardant Health (GH) reported share buybacks of $0 in Q1 2026.

How has Guardant Health's share buybacks changed year-over-year?

Guardant Health's share buybacks decreased by 100.0% year-over-year, from $45.01M to $0.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Guardant Health GH Share Buybacks

Share Buybacks at other companies

IlluminaILMN

$242M+21.0%

Tempus AI, Inc.TEM

$760K—

Fulgent Genetics, Inc.FLGT

$40.08M+362%

Other financials

Income statement

See full

Revenue$301.7M+48.3%

Gross profit$196.7M+52.8%

Operating income-$121.4M-9.3%

Net income-$112.1M-17.8%

EPS (diluted)-$0.85-10.4%

Balance sheet

See full

Cash & equivalents$1.1B+37.0%

Total debt$1.7B+30.5%

Total equity-$181.1M+27.8%

Total assets$1.9B+42.5%

Cash flow

See full

Operating cash flow-$65.6M-4.7%

CapEx$5.6M+25.1%

Free cash flow-$71.2M-6.0%

Valuation

See full

Market cap$19.04B+255%

Enterprise value$19.65B+229%

P/S17.6×+11.2×

Profitability

See full

Gross margin64.9%+3.6pp

Operating margin-41.4%-9.4pp

Net margin-40.1%-8.1pp

FCF margin-22%-6.7pp

Returns & leverage

See full

Return on equity-438.1%-1,655pp

Debt / equity3×—

Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Guardant Health's share buybacks?: Guardant Health (GH) reported share buybacks of $0 in Q1 2026.
How has Guardant Health's share buybacks changed year-over-year?: Guardant Health's share buybacks decreased by 100.0% year-over-year, from $45.01M to $0.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.